Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Dabur India Ltd. Investor Presentation 2018

Nov 13, 2018

59077_rns_2018-11-13_7ce66983-d4b7-4399-8820-8a8772507b28.pdf

Investor Presentation

Open in viewer

Opens in your device viewer

Ref: SEC/SE/2018-19/23 Date: November 13,2018 5

Scrip Code: NSE - DABUR, BSE-500096

To,

Corporate Relation Department Bombay Stock Exchange Ltd. Phiroze Jeejeebhoy Towers Dalal Street, Mumbai - 400 001.

National Stock Exchange of India Ltd. Exchange Plaza, 5th Floor Plot No. C/l, G Block Bandra - Kurla Complex Bandra (E) Mumbai-40005L

,.^^.l. ^^^

'S^^Vh^^^ ^< »»

India Ltd.

7^&^

Sub: Submission of information under Regulation 30 of the SEBI (Listing Obligations & Disclosure Reauirements) Reeulations, 2015

Schedule of Analyst/ Institutional investor Meet

Dear Sir,

Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we wish to inform you that the officials of the Company shall participate in 21st CLSA India Forum (Organized by CLSA Ltd) on 15th November, 2018 at The Oberoi, Gurgaon.

Copy of presentation to be shared with investors in the above said conference is attached.

The aforesaid infomiation is also being disclosed on the website of the Company at www^laburcam.

This is for information and records please.

Thanking you,

Yours faithfully,

For Dabur India Limited

End: as above

Dabur India Limited

Investor Presentation CLSA India Forum – November 2018 1

Agenda

1. Dabur – Overview

    1. Business Structure
    1. India Business
    1. International Business
    1. The way forward
    1. Annexure

Dabur is the largest science-based Ayurveda company

Overview Awards

Established in 1884 – 134 years of trust and excellence

One of the world's largest in Ayurveda and natural healthcare

Having one of the largest distribution network in India, covering ~6.4 mn outlets

20 world class manufacturing facilities catering to needs of diverse markets

Strong overseas presence with ~28% contribution to consolidated sales

Dabur Red Paste rated as 2nd most trusted brand by the consumers in the Oral Care category by the Brand Equity India's Most Trust Brands 2017

Dabur moves up 4 Places in Fortune India 500 List; ranked 163 in the list for 2015

Dabur ranked 25 in the list of Best Companies for CSR in India, according to the Economic Times

Dabur India successfully held the firstever Guinness World Record attempt for the largest simultaneous Nasya Panchkarma Treatment session

Manufacturing facilities located across the globe

One of the largest distribution network in India

Distribution reach of 6.4 mn retail outlets with direct reach of 1.1 mn+

Strong financial profile

  • optically static due to change in accounting standards, demonetization and implementation of GST
  • Steady increase in operating margin, touching 20.9% in FY18

  • PAT has grown at a CAGR of 15% over the last 10 years
  • PAT margin went up to 17.5% in FY18

Note: All figures are in INR bn

FY09 to FY15 is basis IGAAP, FY16 and FY17 are as per IndAS and FY18 is as per IndAS and takes into account GST

Agenda

    1. Dabur Overview
  • 2. Business Structure
    1. India Business
    1. International Business
    1. The way forward
    1. Annexure

Business Structure

Agenda

    1. Dabur Overview
    1. Business Structure

3. India Business

    1. International Business
    1. The way forward
    1. Annexure

The domestic business has seen recovery in the past fiscal year with growth picking up since Q2 FY18…

10 * GST Adjusted Growth The value growth from Q2 FY18 to Q1 FY19 refers to GST adjusted growth

…with broad-based growth…

Category KeyBrands RevenueContribution(FY18) FY18Growth H1 FY19Growth
HealthSupplements 17% 9.4% 18.6%
Healthcare(32%) Digestives 6% 10.2% 16.1%
OTC&Ethicals 9% 3.8% 11.7%
Hair Care 21% 4.1% 18.0%
HPC Oral Care 17% 14.4% 10.0%
(50%) Home Care 7% 13.0% 13.7%
SkinCare 5% 11.0% 19.2%
Foods(18%) Foods 18% 0.7% 14.3%

…and market leadership in most categories

Leading position in key categories across verticals

#Relative Competitive Position 1

Healthcare Home and Personal Care Foods

Drivers of growth – Project Buniyaad 1

Urban Strategy

Leveraging potential through Channel based approach

Rural Strategy

Split the front line teams into two to increase reach and frequency – Showing significant positive gains

Portfolio Focus

Leveraging split teams for focused portfolio building

Enabling Technology

Using technology to track and improve performance and automate processes

New Avenues of Growth

Leveraging the alternate channels of MT and E-comm to grow at a rapid pace

Continue Engagement

Using initiatives and technology to build and continuously motivate the trade and front line teams

Project Buniyaad achieved its direct reach target of 1 mn outlets and also led to doubling of rural sales people to ~1,400

Direct Reach – No. of Outlets

Drivers of growth – 2 Channel Changes

Superstockist, MT and E-comm gaining saliency; Wholesale and Enterprise continues to shrink

Recent Product Launches

Agenda

    1. Dabur Overview
    1. Business Structure
    1. India Business

4. International Business

    1. The way forward
    1. Annexure

International Business – Financial Profile

Sales (INR bn)

  • International Business comprises the Organic and Acquired business
  • Organic business (67% of international) is an extension of Indian portfolio with the same personal care brands operating internationally
  • Acquired business (32% of international) comprises Hobi and Namaste
  • FY17 and FY18 were impacted due to geopolitical headwinds and severe currency devaluation in our key markets

Region-wise Sales (FY18) Performance of Key Markets (H1 FY19)

Constant Currency Growth Rate – H1 FY19

Organic International Business

Organic International Business has evolved from being just a Hair Oil business to a diversified personal care entity

Agenda

    1. Dabur Overview
    1. Business Structure
    1. India Business
    1. International Business

5. The way forward

  1. Annexure

Key Elements

(a) Focus on Core and Scalable Brands

(b) Creating Competitive Leverage

Superiority over mineral oils

Superiority over other Almond HO

2x stronger hair vs Other Amla HO

(d) Driving NPDs

Cost Optimisation and Improving Service Levels

4

Agenda

    1. Dabur Overview
    1. Business Structure
    1. India Business
    1. International Business
    1. The way forward

6. Annexure

Consolidated Profit & Loss

Q2 FY19 Q2 FY18 Y-o-Y (%) H1 FY19 H1 FY18 Y-o-Y (%)
Revenue from operations 2,125.0 1,958.9 8.5% 4,205.7 3,749.0 12.2%
Other Income 81.2 84.3 (3.7%) 154.9 165.6 (6.5%)
Total Income 2,206.2 2,043.2 8.0% 4,360.5 3,914.6 11.4%
Material Cost 1,075.8 977.1 10.1% 2,124.4 1,891.7 12.3%
of%Revenue 506% 499% 50.5% 50.5%
Employee expense 234.3 203.7 15.0% 458.4 407.2 12.6%
%ofRevenue 11.0% 10.4% 109% 109%
Advertisement and publicity 133.5 145.7 (8.4%) 332.5 295.7 12.4%
of%Revenue 63% 7.4% 7.9% 7.9%
Other Expenses 230.5 212.5 8.5% 453.4 425.6 6.5%
%ofRevenue 108% 108% 108% 11.4%
Operating Profit 450.8 419.9 7.4% 836.9 728.8 14.8%
%ofRevenue 21.2% 21.4% 19.9% 19.4%
EBITDA 532.1 504.2 5.5% 991.8 894.4 10.9%
of%Revenue 25.0% 25.7% 23.6% 23.9%
Finance Costs 15.6 13.3 16.8% 30.4 26.6 14.4%
Depreciation & Amortization 43.1 40.1 7.5% 85.8 79.1 8.5%
Profit before exceptional items, tax andshare of profit/(loss) from joint venture 473.4 450.8 5.0% 875.5 788.6 11.0%
%ofRevenue 223% 230% 208% 210%
Share of profit / (loss) of joint venture 0.3 (0.2) n.m. 0.5 0.3 n.m.
Exceptional item(s) 0.0 0.0 n.a. 0.0 14.5 (100.0%)
Tax Expenses 96.1 87.9 9.3% 168.5 146.8 14.7%
Net profit after tax and after share ofprofit/(loss) from joint venture 377.6 362.7 4.1% 707.5 627.5 12.8%
%ofRevenue 17.8% 18.5% 168% 16.7%
Non controlling interest 0.9 0.7 25.2% 1.7 1.5 16.4%
Net profit for the period/year 376.6 361.9 4.1% 705.8 626.1 12.7%
%ofRevenue 17.7% 18.5% 16.8% 16.7%

Standalone Profit & Loss

Q2 FY19 Q2 FY18 Y-o-Y (%) H1 FY19 H1 FY18 Y-o-Y (%)
Revenue from operations 1,537.2 1,416.4 8.5% 3,010.3 2,650.1 13.6%
Other Income 75.7 76.2 (0.7%) 144.3 151.8 (4.9%)
Total Income 1,612.9 1,492.6 8.1% 3,154.6 2,801.9 12.6%
Material Cost 790.7 737.8 7.2% 1,573.1 1,411.3 11.5%
%ofRevenue 51.4% 52.1% 523% 533%
Employee expense 143.3 117.3 22.2% 281.3 236.5 18.9%
%ofRevenue 93% 83% 93% 89%
Advertisement and publicity 111.2 114.7 (3.0%) 266.9 233.4 14.3%
of%Revenue 7.2% 8.1% 89% 88%
Other Expenses 140.5 127.8 10.0% 281.1 260.5 7.9%
%ofRevenue 9.1% 90% 93% 98%
Operating Profit 351.5 318.8 10.3% 608.0 508.4 19.6%
%ofRevenue 22.9% 22.5% 20.2% 19.2%
EBITDA 427.2 395.0 8.1% 752.3 660.2 13.9%
of%Revenue 27.8% 27.9% 25.0% 24.9%
Finance Costs 8.1 5.0 62.3% 13.9 10.8 29.6%
Depreciation & Amortization 26.2 25.5 2.6% 52.2 50.0 4.4%
Profit before exceptional items, tax andshare of profit/(loss) from joint venture 392.9 364.5 7.8% 686.1 599.4 14.5%
of%Revenue 256% 25.7% 228% 226%
Exceptional item(s) 0.0 0.0 n.a. 0.0 14.5 (100.0%)
Tax Expenses 85.7 81.1 5.6% 148.3 131.9 12.4%
Net profit for the period/year 307.3 283.4 8.4% 537.8 453.0 18.7%
%ofRevenue 20.0% 20.0% 17.9% 17.1%

Consolidated Balance Sheet

Particulars As at30/09/2018(Unaudited) As at31/03/2018(Audited)
A Assets
1 Non-current assets
(a)Property, plant and equipment 1,552 1,552
(b)Capital work-in-progress 39 42
(c)Investment property 54 54
(d)Goodwill 411 412
(e)Other Intangible assets 35 10
(f)Financial assets
(i)Investments 3,042 3,092
(ii)Loans 15 13
(iii)Others 7 4
(g)Non-current tax assets (net) 3 3
(h)Other non-current assets 79 80
Total Non-current assets 5,237 5,262
2 Current assets
(a)Inventories 1,282 1,256
(b)Financial assets
(i)Investments 271 713
(ii)Trade receivables 772 706
(iii)Cash and cash equivalents 96 154
Bank Balances other than (iii)(iv)above 96 152
(v)Loans 8 35
(vi)Others 3 28
(c)Current tax asset(net) 2 2
(d)Other current assets 373 391
(e)Assets held for sale 2 2
Total current assets 2,906 3,440
Particulars As at30/09/2018(Unaudited) As at31/03/2018(Audited)
BEquity and Liabilities
1Equity
(a)Equity share capital 177 176
(b)Other Equity 4,956 5,530
Equity attributable to shareholders of theCompany 5,133 5,707
Non Controlling Interest 31 27
Total equity 5,163 5,733
2Non-current liabilities
(a)Financial liabilities
(i)Borrowings 42 364
(ii)Other financial liabilities 4 4
(b)Provisions 58 57
(c)Deferred tax liabilities (Net) 99 109
Total Non-current liabilities 203 534
3Current liabilities
(a)Financial liabilities
(i)Borrowings 671 464
(ii)Trade payables 1,343 1,410
(iii)Other financial liabilities 349 238
(b)Other current liabilities 223 173
(c)Provisions 139 107
(d)Current tax Liabilities (Net) 50 41
Total Current liabilities 2,776 2,434
Total Equity and Liabilities 8,143 8,702

Standalone Balance Sheet

Particulars As at30/09/2018(Unaudited) As at31/03/2018(Audited)
AAssets
1 Non-current assets
(a) Property, plant and equipment 951 971
(b) Capital work-in-progress 31 27
(c) Investment property 50 50
(d) Other Intangible assets 16 9
(e) Financial assets
(i)Investments 2,620 2,720
(ii)Loans 10 10
(iii)Others 7 4
(f) Non-current tax assets (net) 3 3
(g) Other non-current assets 59 60
Total Non-current assets 3,747 3,854
2 Current assets
(a) Inventories 739 705
(b) Financial assets
(i)Investments 269 713
(ii)Trade receivables 313 321
(iii)Cash and cash equivalents 13 78
Bank Balances other than (iii)(iv)above 10 9
(v)Loans 1 1
(vi)Others 8 4
(c) Other current assets 111 127
Total current assets 1,465 1,959
Particulars As at30/09/2018(Unaudited) As at31/03/2018(Audited)
B Equity and Liabilities
1 Equity
(a) Equity share capital 177 176
(b) Other Equity 3,262 4,051
Total equity 3,438 4,227
2 Non-current liabilities
(a) Financial liabilities
(i)Borrowings 26 201
(ii)Other financial liabilities 4 4
(b) Provisions 52 50
(c) Deferred tax liabilities (Net) 84 96
Total Non-current liabilities 167 351
3 Current liabilities
(a) Financial liabilities
(i)Borrowings 251 85
(ii)Trade payables 955 961
(iii)Other financial liabilities 242 82
(b) Other current liabilities 58 38
(c) Provisions 89 64
(d) Current tax Liabilities (Net) 11 4
Total Current liabilities 1,607 1,234
Total Equity and Liabilities 5,212 5,813

For more information & updates, Contact: Gagan Ahluwalia ([email protected])

Ankit Joshi ([email protected])